DPP4 and type 2 diabetes mellitus: Inspired by this study, we started scanning the chemical structures of known FDA approved drugs for repurposing and were intrigued by dipeptidyl peptidase IV (DPP4 or CD26) inhibitors which are used in the treatment of type-2 diabetes [9,10,11,12].